Shivalik Rasayan Limited - agriculture in Dehradun, Uttarakhand, India. FY 2026 financials and compliance.
CIN L24237UR1979PLC005041 Incorporated 16 March 1979 ROC Uttarakhand HQ Dehradun, Uttarakhand, India
Active Listed - NSE: SHIVALIK · BSE: 539148 Public Limited Company agriculture
Data last updated
Revenue · FY 2026
₹368 Cr
▲ 18.04% YoY
EBITDA · FY 2026
₹49.84 Cr
▲ 2.74% YoY
Net profit · FY 2026
₹17.97 Cr
▼ 12.02% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹7.88 Cr
Issued & subscribed
Open charges
₹110.2 Cr
Satisfied ₹21.54 Cr
Company age
47 yrs
Est. 1979
Last financials
Mar 2025
Balance sheet date

About Shivalik Rasayan Limited

Data last updated: 23 December 2025

Shivalik Rasayan Limited is a public limited company based in Dehradun, Uttarakhand, India, a subsidiary of Growel Remedies Limited. It specialises in crop protection, a part of the broader agriculture sector. Incorporated on 16 March 1979, the company has been in operation for over 47 years.

Registered with ROC Uttarakhand under CIN L24237UR1979PLC005041. Listed on BSE: 539148 and NSE: SHIVALIK.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.88 Cr. Formerly known as Shivalik Rasayan Udyog Limited. It is led by directors including Ramit Madan and Vimal Kumar Shrawat.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Village Kolhupani Post Office Chandanwari Via Prem Nagar, Dehradun, Uttarakhand, India – 248007.

As per the financials filed for FY 2025, the company reported a revenue of ₹320.08 Cr, a growth of 16% compared to the previous year.

It operates as a subsidiary of Growel Remedies Limited.

The company is associated with 2 brands - Shivalik Rasayan, Shivalik Rasayan Limited. As per MCA filings, the company has open charges of ₹110.2 Cr and satisfied charges of ₹21.54 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivalikrasayan.com.

Company Details of Shivalik Rasayan Limited
CIN L24237UR1979PLC005041
Registration Number 005041
Incorporation Date 16 March 1979
ROC Uttarakhand
Listing Status Listed (BSE: 539148, NSE: SHIVALIK)
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Growel Remedies Limited
Compliance Status Active Compliant
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Social Media
  • Registered Address
    Village Kolhupani Post Office Chandanwari Via Prem Nagar, Dehradun, Uttarakhand, India – 248007
  • Industry
    Agriculture, Crop Protection
Company report
Shivalik Rasayan Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Shivalik Rasayan Limited report

Financials, compliance, directors, charges, ownership and filings for Shivalik Rasayan Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Shivalik Rasayan Limited

Shivalik Rasayan Limited operates two associated brands: Shivalik Rasayan and Shivalik Rasayan Limited. These brands represent Shivalik Rasayan Limited's diversified market presence and brand portfolio.

Brand Description Website
Organophosphorus insecticides are manufactured and supplied for agriculture. shivalikrasayan.in
Shivalik Rasayan Limited is engaged in manufacturing APIs and agrochemicals. shivalikrasayan.com

Competitors & Alternatives of Shivalik Rasayan Limited

Brands and companies operating in the same space as Shivalik Rasayan Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.

Competitor Description Location Founded
WuXi AppTec WuXi AppTec Provider of CRO and CDMO services Shanghai, China, China 2000
ANI Pharmaceuticals ANI Pharmaceuticals Branded and generic prescription drugs are developed, manufactured, and marketed. Baudette, United States, United States 1996
Aptar Aptar Regulatory support, brand differentiation, and prototyping services are provided. Crystal Lake, United States, United States 1992
CHEPLAPHARM CHEPLAPHARM Branded pharmaceutical products are developed, marketed, and distributed globally. Mesekenhagen, Germany, Germany 1998
Red Nucleus Red Nucleus Advisory, scientific, and medical communications provided for pharmaceutical industry. Yardley, United States, United States 2014
Ipsen Ipsen Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes - 1929
Eurofins Scientific Eurofins Scientific Laboratory testing and contract research services are provided globally. Luxembourg, Luxembourg, Luxembourg 1987
China Medical System China Medical System Generic formulations including tablets, capsules, liquids, and injectables are manufactured. Shenzhen, China, China 1992
Aliada Therapeutics Aliada Therapeutics Provider of drug research & development services for multiple therapeutic areas Boston, United States, United States 2021

Business Activity of Shivalik Rasayan Limited

Shivalik Rasayan Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Shivalik Rasayan Limited

Shivalik Rasayan Limited is audited by M/s Rahul Chaudhary & Associates, Chartered Accountants (ICAI peer reviewed, certificate valid till 2026-09-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s Rahul Chaudhary & Associates, Chartered Accountants (ICAI peer reviewed, certificate valid till 2026-09-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Shivalik Rasayan Limited

Shivalik Rasayan Limited is currently managed by 13 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ramit Madan Director 13 Aug 2024 1 Years 10 Months Current
Vimal Kumar Shrawat Managing Director 17 Nov 2018 7 Years 7 Months Current
Shaival Saurabh Director 13 Aug 2024 1 Years 10 Months Current
Rahul Bishnoi Director 23 Feb 2002 24 Years 4 Months Current
Suresh Kumar Singh Whole-Time Director 15 Dec 1997 28 Years 6 Months Current
Ravi Kumar Bansal Director 14 Aug 2019 6 Years 10 Months Current
Showing 6 of 13 current directors. View all directors

Financials of Shivalik Rasayan Limited FY 2026 filings available

Shivalik Rasayan Limited reported revenue of ₹368 Cr (up 18.04% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹368 Cr ▲ 18.04%
Profit · FY 2026
₹17.97 Cr ▼ 12.02%
EBITDA · FY 2026
₹49.84 Cr ▲ 2.74%
Revenue₹ Cr · Consolidated0200400FY 2022: ₹215 Cr215FY 2022FY 2023: ₹234 Cr · +9.2% YoY234+9.2%FY 2023FY 2024: ₹273 Cr · +16.4% YoY273+16.4%FY 2024FY 2025: ₹312 Cr · +14.2% YoY312+14.2%FY 2025FY 2026: ₹368 Cr · +18% YoY368+18%FY 2026
Net Profit₹ Cr · Consolidated02040FY 2022: ₹34 Cr34.3FY 2022FY 2023: ₹30 Cr · -12.9% YoY29.8-12.9%FY 2023FY 2024: ₹18 Cr · -39.4% YoY18.1-39.4%FY 2024FY 2025: ₹20 Cr · +13% YoY20.4+13%FY 2025FY 2026: ₹18 Cr · -12% YoY18-12%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year050100150Q1'25: ₹75 Cr · +15.8% YoY74.6+15.8%Q1'25Q2'25: ₹82 Cr · +23% YoY82.4+23%Q2'25Q3'25: ₹85 Cr · +21.5% YoY85.3+21.5%Q3'25Q4'25: ₹69 Cr · -2.6% YoY69.4-2.6%Q4'25Q1'26: ₹89 Cr · +19.7% YoY89.3+19.7%Q1'26Q2'26: ₹94 Cr · +13.8% YoY93.8+13.8%Q2'26Q3'26: ₹82 Cr · -3.8% YoY82-3.8%Q3'26Q4'26: ₹103 Cr · +48.2% YoY103+48.2%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Revenue from Operations ₹368 Cr ₹311.77 Cr ₹272.98 Cr ₹234.45 Cr ₹214.75 Cr
Other Income ₹4.08 Cr ₹8.31 Cr ₹3.98 Cr ₹4.66 Cr ₹3.71 Cr
Total Income ₹372.08 Cr ₹320.08 Cr ₹276.96 Cr ₹239.11 Cr ₹218.46 Cr
Cost of Materials Consumed ₹196.99 Cr ₹173.45 Cr ₹156.08 Cr ₹132.66 Cr ₹101.92 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹8.62 Cr -₹13.04 Cr -₹16.23 Cr -₹17.94 Cr -₹7.81 Cr
Employee Benefit Expense ₹60.55 Cr ₹55.02 Cr ₹46.82 Cr ₹36.94 Cr ₹29.82 Cr
Finance Costs ₹9.6 Cr ₹9.33 Cr ₹7.63 Cr ₹4.34 Cr ₹2.5 Cr
Depreciation & Amortisation ₹18.77 Cr ₹15.77 Cr ₹12.38 Cr ₹11.6 Cr ₹11.01 Cr
Other Expenses ₹73.31 Cr ₹56.14 Cr ₹47.14 Cr ₹39.85 Cr ₹44.06 Cr
Total Expenses ₹350.61 Cr ₹296.67 Cr ₹253.81 Cr ₹207.45 Cr ₹181.5 Cr
Profit Before Exceptional Items & Tax ₹21.48 Cr ₹23.41 Cr ₹23.15 Cr ₹31.66 Cr ₹36.96 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹21.48 Cr ₹23.41 Cr ₹23.15 Cr ₹31.66 Cr ₹36.96 Cr
Total Tax Expense ₹3.51 Cr ₹2.98 Cr ₹5.08 Cr ₹1.83 Cr ₹2.7 Cr
Net Profit ₹17.97 Cr ₹20.42 Cr ₹18.07 Cr ₹29.83 Cr ₹34.25 Cr
  attributable to Owners ₹12.14 Cr ₹16.69 Cr ₹16.36 Cr - ₹0
  attributable to NCI ₹5.83 Cr ₹3.73 Cr ₹1.71 Cr - ₹0
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹17.97 Cr ₹20.42 Cr ₹18.07 Cr ₹29.83 Cr ₹34.25 Cr
EBITDA (computed) ₹49.84 Cr ₹48.51 Cr ₹43.16 Cr ₹47.61 Cr ₹50.46 Cr
Basic EPS ₹7.71 ₹10.60 ₹10.75 ₹15.02 ₹18.12
Diluted EPS ₹7.71 ₹10.60 ₹10.75 ₹15.02 ₹18.12
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹818.87 Cr ₹734.02 Cr ₹692.47 Cr ₹578.24 Cr
Non-current Assets ₹436.79 Cr ₹416.64 Cr ₹398.56 Cr ₹316.69 Cr
Current Assets ₹382.08 Cr ₹317.39 Cr ₹293.91 Cr ₹261.56 Cr
Property, Plant & Equipment ₹334 Cr ₹335.66 Cr ₹213.11 Cr ₹217.29 Cr
Inventories ₹146.87 Cr ₹117.7 Cr ₹101.83 Cr ₹74.99 Cr
Trade Receivables ₹115.14 Cr ₹96.12 Cr ₹86.74 Cr ₹84.77 Cr
Cash & Equivalents ₹34.37 Cr ₹27.97 Cr ₹37.74 Cr ₹30.67 Cr
Equity (Net Worth) ₹599.1 Cr ₹535.96 Cr ₹507.57 Cr ₹419.28 Cr
Equity Share Capital ₹7.88 Cr ₹7.88 Cr ₹7.78 Cr ₹7.24 Cr
Borrowings (Non-current) ₹26.18 Cr ₹16.5 Cr ₹23.97 Cr ₹13.01 Cr
Borrowings (Current) ₹87.46 Cr ₹77.38 Cr ₹52.11 Cr ₹44.7 Cr
Total Debt (computed) ₹113.64 Cr ₹93.88 Cr ₹76.08 Cr ₹57.71 Cr
Current Liabilities ₹190.18 Cr ₹178.2 Cr ₹158.44 Cr ₹143.56 Cr
Total Liabilities ₹219.76 Cr ₹198.06 Cr ₹184.9 Cr ₹158.96 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹33.96 Cr -₹7.58 Cr -₹6.36 Cr -₹18.95 Cr ₹9.89 Cr
Investing Cash Flow -₹21.23 Cr -₹12.52 Cr -₹85.81 Cr -₹70.77 Cr -₹23.36 Cr
Financing Cash Flow ₹61.58 Cr ₹10.33 Cr ₹99.24 Cr ₹49.63 Cr ₹79.45 Cr
Capital Expenditure ₹23.32 Cr ₹20.83 Cr ₹79.16 Cr ₹63.23 Cr ₹24.97 Cr
Free Cash Flow (computed) -₹57.28 Cr -₹28.41 Cr -₹85.52 Cr -₹82.18 Cr -₹15.08 Cr
Dividends Paid ₹2.14 Cr ₹2.05 Cr ₹2.01 Cr ₹72.44 Lakh ₹68.9 Lakh
Net Change in Cash ₹6.4 Cr -₹9.77 Cr ₹7.07 Cr -₹40.09 Cr ₹70.76 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹102.82 Cr ₹82.04 Cr ₹93.84 Cr ₹89.31 Cr ₹69.39 Cr ₹85.31 Cr ₹82.44 Cr ₹74.63 Cr ₹71.23 Cr ₹70.23 Cr ₹67.05 Cr ₹64.47 Cr
Other Income ₹1.92 Cr ₹1.18 Cr ₹38.84 Lakh ₹59.71 Lakh ₹5.71 Cr ₹1.6 Cr ₹35.43 Lakh ₹63.82 Lakh ₹1.49 Cr ₹1.5 Cr ₹56.13 Lakh ₹42.22 Lakh
Total Income ₹104.73 Cr ₹83.21 Cr ₹94.23 Cr ₹89.91 Cr ₹75.1 Cr ₹86.91 Cr ₹82.8 Cr ₹75.27 Cr ₹72.73 Cr ₹71.74 Cr ₹67.61 Cr ₹64.89 Cr
Cost of Materials Consumed ₹49.17 Cr ₹49.17 Cr ₹53.29 Cr ₹45.36 Cr ₹28.97 Cr ₹54.25 Cr ₹52.34 Cr ₹37.88 Cr ₹38.62 Cr ₹39.17 Cr ₹39.67 Cr ₹38.62 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹6.34 Cr -₹11.07 Cr -₹6.36 Cr ₹2.47 Cr ₹3.83 Cr -₹11.51 Cr -₹8.98 Cr ₹3.63 Cr -₹1.76 Cr -₹2.8 Cr -₹5.12 Cr -₹6.55 Cr
Employee Benefit Expense ₹15.64 Cr ₹15.24 Cr ₹15.66 Cr ₹14.01 Cr ₹14.83 Cr ₹13.92 Cr ₹13.98 Cr ₹12.3 Cr ₹12.8 Cr ₹12.69 Cr ₹11.13 Cr ₹10.2 Cr
Finance Costs ₹2.46 Cr ₹2.31 Cr ₹2.22 Cr ₹2.62 Cr ₹2.71 Cr ₹2.26 Cr ₹2.45 Cr ₹1.92 Cr ₹2.61 Cr ₹1.58 Cr ₹1.96 Cr ₹1.47 Cr
Depreciation & Amortisation ₹4.16 Cr ₹5.06 Cr ₹4.73 Cr ₹4.82 Cr ₹2.78 Cr ₹4.84 Cr ₹4.66 Cr ₹3.5 Cr ₹3.11 Cr ₹3.01 Cr ₹3.44 Cr ₹2.81 Cr
Other Expenses ₹19.24 Cr ₹18.37 Cr ₹19.21 Cr ₹16.49 Cr ₹16 Cr ₹15.34 Cr ₹13.35 Cr ₹11.44 Cr ₹12.29 Cr ₹12.31 Cr ₹11.7 Cr ₹10.84 Cr
Total Expenses ₹97.01 Cr ₹79.09 Cr ₹88.75 Cr ₹85.76 Cr ₹69.13 Cr ₹79.09 Cr ₹77.79 Cr ₹70.66 Cr ₹67.67 Cr ₹65.96 Cr ₹62.8 Cr ₹57.38 Cr
Profit Before Exceptional Items & Tax ₹7.73 Cr ₹4.13 Cr ₹5.48 Cr ₹4.15 Cr ₹5.98 Cr ₹7.82 Cr ₹5.01 Cr ₹4.6 Cr ₹5.06 Cr ₹5.77 Cr ₹4.81 Cr ₹7.51 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹7.73 Cr ₹4.13 Cr ₹5.48 Cr ₹4.15 Cr ₹5.98 Cr ₹7.82 Cr ₹5.01 Cr ₹4.6 Cr ₹5.06 Cr ₹5.77 Cr ₹4.81 Cr ₹7.51 Cr
Total Tax Expense ₹55.31 Lakh ₹45.72 Lakh ₹1.17 Cr ₹1.33 Cr ₹78.55 Lakh ₹88.23 Lakh ₹58.04 Lakh ₹73.66 Lakh ₹45.58 Lakh ₹1.43 Cr ₹2.17 Cr ₹1.03 Cr
Net Profit ₹7.17 Cr ₹3.67 Cr ₹4.3 Cr ₹2.82 Cr ₹5.19 Cr ₹6.94 Cr ₹4.43 Cr ₹3.87 Cr ₹4.6 Cr ₹4.34 Cr ₹2.65 Cr ₹6.48 Cr
  attributable to Owners ₹4.53 Cr ₹2.7 Cr ₹3.05 Cr ₹1.6 Cr ₹4.13 Cr - ₹4.01 Cr ₹3.52 Cr ₹3.44 Cr ₹3.06 Cr ₹1.88 Cr -
  attributable to NCI ₹2.65 Cr ₹97.33 Lakh ₹1.26 Cr ₹1.22 Cr ₹1.06 Cr - ₹41.75 Lakh ₹34.34 Lakh ₹1.16 Cr ₹1.28 Cr ₹76.61 Lakh -
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹7.17 Cr ₹3.67 Cr ₹4.3 Cr ₹2.82 Cr ₹5.19 Cr ₹6.94 Cr ₹4.43 Cr ₹3.87 Cr ₹4.6 Cr ₹4.34 Cr ₹2.65 Cr ₹6.48 Cr
EBITDA (computed) ₹14.34 Cr ₹11.5 Cr ₹12.42 Cr ₹11.58 Cr ₹11.47 Cr ₹14.91 Cr ₹12.11 Cr ₹10.02 Cr ₹10.78 Cr ₹10.37 Cr ₹10.22 Cr ₹11.79 Cr
Basic EPS ₹2.87 ₹1.71 ₹1.93 ₹1.02 ₹2.62 ₹3.39 ₹2.58 ₹2.27 ₹2.26 ₹2.03 ₹1.26 ₹2.28
Diluted EPS ₹2.87 ₹1.71 ₹1.93 ₹1.02 ₹2.62 ₹3.39 ₹2.58 ₹2.27 ₹2.26 ₹2.03 ₹1.26 ₹2.28
Latest 12 quarters shown of 18 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Agrochemicals ₹34.44 Cr ₹2.68 Cr ₹317.12 Cr ₹59.78 Cr
Active Pharma Ingredient (API) ₹4.74 Cr ₹2.06 Cr ₹125.69 Cr ₹12.1 Cr
Pharma Formulation ₹60.65 Cr ₹5.44 Cr ₹356.09 Cr ₹48.47 Cr
Unallacated other operating revenue ₹2.99 Cr ₹0 ₹0 ₹0
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Agrochemicals ₹151.26 Cr ₹22.02 Cr - -
Active Pharma Ingredient (API) ₹9.05 Cr -₹6.43 Cr - -
Pharma Formulation ₹197.77 Cr ₹15.48 Cr - -
Unallacated other operating revenue ₹9.93 Cr ₹0 - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹170.23 Cr ₹149.23 Cr ₹93.68 Cr ₹93.58 Cr
Other Income ₹96.45 Lakh ₹2.06 Cr ₹1.65 Cr ₹2.2 Cr
Total Income ₹171.2 Cr ₹151.29 Cr ₹95.33 Cr ₹95.78 Cr
Cost of Materials Consumed ₹102.65 Cr ₹82.8 Cr ₹51.38 Cr ₹50.85 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹16.04 Cr -₹7.01 Cr -₹4.13 Cr -₹8.23 Cr
Employee Benefit Expense ₹25.86 Cr ₹23.15 Cr ₹16.75 Cr ₹16.49 Cr
Finance Costs ₹6.1 Cr ₹6.18 Cr ₹3.23 Cr ₹1.42 Cr
Depreciation & Amortisation ₹11.55 Cr ₹8.7 Cr ₹5.28 Cr ₹5.24 Cr
Other Expenses ₹31.59 Cr ₹23.94 Cr ₹12.74 Cr ₹15.39 Cr
Total Expenses ₹161.71 Cr ₹137.76 Cr ₹85.25 Cr ₹81.16 Cr
Profit Before Exceptional Items & Tax ₹9.49 Cr ₹13.53 Cr ₹10.08 Cr ₹14.62 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹9.49 Cr ₹13.53 Cr ₹10.08 Cr ₹14.62 Cr
Total Tax Expense ₹1.32 Cr -₹33.95 Lakh ₹1.5 Cr -₹48.77 Lakh
Net Profit ₹8.17 Cr ₹13.87 Cr ₹8.58 Cr ₹15.1 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹8.17 Cr ₹13.87 Cr ₹8.58 Cr ₹15.1 Cr
EBITDA (computed) ₹27.14 Cr ₹28.41 Cr ₹18.59 Cr ₹21.27 Cr
Basic EPS ₹5.19 ₹8.80 ₹5.63 ₹10.42
Diluted EPS ₹5.19 ₹8.80 ₹5.63 ₹10.42
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹527.97 Cr ₹511.61 Cr ₹471.37 Cr ₹364.67 Cr
Non-current Assets ₹369.62 Cr ₹358.77 Cr ₹332.74 Cr ₹260.8 Cr
Current Assets ₹158.35 Cr ₹152.84 Cr ₹138.63 Cr ₹103.87 Cr
Property, Plant & Equipment ₹249.91 Cr ₹249.54 Cr ₹122.16 Cr ₹125.53 Cr
Inventories ₹76.79 Cr ₹55.56 Cr ₹42.45 Cr ₹29.93 Cr
Trade Receivables ₹33.31 Cr ₹27.22 Cr ₹31.48 Cr ₹19.52 Cr
Cash & Equivalents ₹3.1 Cr ₹24.21 Cr ₹22.95 Cr ₹9.89 Cr
Equity (Net Worth) ₹404.65 Cr ₹397.65 Cr ₹374.04 Cr ₹290.81 Cr
Equity Share Capital ₹7.88 Cr ₹7.88 Cr ₹7.78 Cr ₹7.24 Cr
Borrowings (Non-current) ₹20.03 Cr ₹12.77 Cr ₹22.71 Cr ₹12.14 Cr
Borrowings (Current) ₹45.83 Cr ₹47.86 Cr ₹22.55 Cr ₹21.39 Cr
Total Debt (computed) ₹65.86 Cr ₹60.63 Cr ₹45.26 Cr ₹33.53 Cr
Current Liabilities ₹102.26 Cr ₹100.04 Cr ₹73.88 Cr ₹60.99 Cr
Total Liabilities ₹123.33 Cr ₹113.96 Cr ₹97.33 Cr ₹73.86 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow -₹1.26 Cr -₹1.04 Cr ₹47.2 Lakh -₹12.66 Cr
Investing Cash Flow -₹18.19 Cr -₹19.71 Cr -₹80.25 Cr -₹64.89 Cr
Financing Cash Flow -₹1.66 Cr ₹22.01 Cr ₹92.84 Cr ₹20.51 Cr
Capital Expenditure ₹18.54 Cr ₹20.74 Cr ₹72.87 Cr ₹56.63 Cr
Free Cash Flow (computed) -₹19.8 Cr -₹21.78 Cr -₹72.4 Cr -₹69.29 Cr
Dividends Paid ₹78.75 Lakh ₹77.8 Lakh ₹74.55 Lakh ₹72.44 Lakh
Net Change in Cash -₹21.11 Cr ₹1.26 Cr ₹13.06 Cr -₹57.04 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹42.17 Cr ₹35.13 Cr ₹46.67 Cr ₹46.26 Cr ₹39.78 Cr ₹40.16 Cr ₹37.7 Cr ₹31.58 Cr ₹23.92 Cr ₹23.73 Cr ₹23.51 Cr ₹22.52 Cr
Other Income ₹18.12 Lakh ₹64.09 Lakh ₹1.56 Lakh ₹12.68 Lakh ₹48.29 Lakh ₹1.46 Cr ₹6.47 Lakh ₹5.19 Lakh ₹92.59 Lakh ₹67.11 Lakh ₹1.15 Lakh ₹4.3 Lakh
Total Income ₹42.35 Cr ₹35.77 Cr ₹46.69 Cr ₹46.39 Cr ₹40.26 Cr ₹41.63 Cr ₹37.76 Cr ₹31.63 Cr ₹24.84 Cr ₹24.4 Cr ₹23.52 Cr ₹22.57 Cr
Cost of Materials Consumed ₹23.08 Cr ₹27.48 Cr ₹31.32 Cr ₹20.76 Cr ₹17.45 Cr ₹25.73 Cr ₹23.4 Cr ₹16.22 Cr ₹16.79 Cr ₹10.07 Cr ₹12.01 Cr ₹12.51 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹23.25 Lakh -₹13.09 Cr -₹7.55 Cr ₹4.36 Cr ₹1.58 Cr -₹5.31 Cr -₹4.48 Cr ₹1.2 Cr -₹3.54 Cr ₹1.32 Cr -₹60.22 Lakh -₹1.31 Cr
Employee Benefit Expense ₹6.24 Cr ₹6.87 Cr ₹6.83 Cr ₹5.92 Cr ₹6.43 Cr ₹5.91 Cr ₹6.34 Cr ₹4.46 Cr ₹4.41 Cr ₹4.68 Cr ₹4.03 Cr ₹3.63 Cr
Finance Costs ₹2.07 Cr ₹1.34 Cr ₹1.23 Cr ₹1.46 Cr ₹2.06 Cr ₹1.5 Cr ₹1.41 Cr ₹1.21 Cr ₹72.36 Lakh ₹93.41 Lakh ₹1.06 Cr ₹51.63 Lakh
Depreciation & Amortisation ₹2.43 Cr ₹3.24 Cr ₹2.87 Cr ₹3.01 Cr ₹2.3 Cr ₹2.63 Cr ₹2.05 Cr ₹1.72 Cr ₹1.34 Cr ₹1.21 Cr ₹1.62 Cr ₹1.12 Cr
Other Expenses ₹5.63 Cr ₹7.92 Cr ₹9.18 Cr ₹8.86 Cr ₹6.95 Cr ₹7.23 Cr ₹5.99 Cr ₹3.77 Cr ₹2.71 Cr ₹3.7 Cr ₹3.06 Cr ₹3.27 Cr
Total Expenses ₹39.68 Cr ₹33.75 Cr ₹43.89 Cr ₹44.38 Cr ₹36.78 Cr ₹37.68 Cr ₹34.71 Cr ₹28.58 Cr ₹22.44 Cr ₹21.9 Cr ₹21.17 Cr ₹19.74 Cr
Profit Before Exceptional Items & Tax ₹2.67 Cr ₹2.02 Cr ₹2.79 Cr ₹2.02 Cr ₹3.49 Cr ₹3.94 Cr ₹3.05 Cr ₹3.05 Cr ₹2.4 Cr ₹2.5 Cr ₹2.35 Cr ₹2.82 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹2.67 Cr ₹2.02 Cr ₹2.79 Cr ₹2.02 Cr ₹3.49 Cr ₹3.94 Cr ₹3.05 Cr ₹3.05 Cr ₹2.4 Cr ₹2.5 Cr ₹2.35 Cr ₹2.82 Cr
Total Tax Expense -₹5.96 Lakh -₹1.91 Lakh ₹60.29 Lakh ₹79.46 Lakh ₹15.88 Lakh -₹7.26 Lakh -₹40.45 Lakh -₹2.11 Lakh -₹15.94 Lakh ₹18.89 Lakh ₹1.18 Cr ₹29.03 Lakh
Net Profit ₹2.73 Cr ₹2.03 Cr ₹2.19 Cr ₹1.22 Cr ₹3.33 Cr ₹4.02 Cr ₹3.45 Cr ₹3.07 Cr ₹2.56 Cr ₹2.31 Cr ₹1.17 Cr ₹2.53 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹2.73 Cr ₹2.03 Cr ₹2.19 Cr ₹1.22 Cr ₹3.33 Cr ₹4.02 Cr ₹3.45 Cr ₹3.07 Cr ₹2.56 Cr ₹2.31 Cr ₹1.17 Cr ₹2.53 Cr
EBITDA (computed) ₹7.17 Cr ₹6.59 Cr ₹6.89 Cr ₹6.49 Cr ₹7.85 Cr ₹8.06 Cr ₹6.51 Cr ₹5.99 Cr ₹4.46 Cr ₹4.64 Cr ₹5.03 Cr ₹4.46 Cr
Basic EPS ₹1.73 ₹1.29 ₹1.39 ₹0.78 ₹2.11 ₹2.58 ₹2.22 ₹1.97 ₹1.68 ₹1.55 ₹0.79 ₹1.75
Diluted EPS ₹1.73 ₹1.29 ₹1.39 ₹0.78 ₹2.11 ₹2.58 ₹2.22 ₹1.97 ₹1.68 ₹1.55 ₹0.79 ₹1.75
Latest 12 quarters shown of 16 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Agrochemicals ₹34.44 Cr ₹2.68 Cr ₹317.12 Cr ₹59.78 Cr
Active Pharma Ingredient (API) ₹4.74 Cr ₹2.06 Cr ₹125.69 Cr ₹12.1 Cr
Pharma Formulation ₹0 ₹0 ₹0 ₹0
Unallacated other operating revenue ₹2.99 Cr ₹0 ₹0 ₹0
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Agrochemicals ₹151.26 Cr ₹22.02 Cr - -
Active Pharma Ingredient (API) ₹9.05 Cr -₹6.43 Cr - -
Pharma Formulation ₹0 ₹0 - -
Unallacated other operating revenue ₹9.93 Cr ₹0 - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Shivalik Rasayan Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Shivalik Rasayan Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 47.37%, foreign institutional investors hold 4.20%, retail and other public shareholders hold 48.42% of Shivalik Rasayan Limited. The company had 13,413 shareholders on record.

Promoters: 47.37%FII (Foreign Institutional): 4.20%Retail & Others: 48.42%
Mar 2026
QUARTER
47.37% Promoters
4.20% FII (Foreign Institutional)
48.42% Retail & Others
Promoter holding - history
Now 47.37% · Mar 2026High 50.32% · Nov 2021Low 47.37% · Mar 2025
46%47.5%49%50.5%52%Nov 2021Sep 2022Jun 2023Jun 2024Jun 2025Nov 2021: 50.32%Dec 2021: 50.32%Mar 2022: 50.32%Jun 2022: 50.32%Sep 2022: 50.32%Dec 2022: 50.32%Mar 2023: 50.32%Apr 2023: 50.05%Jun 2023: 50.05%Sep 2023: 47.95%Dec 2023: 47.95%Mar 2024: 47.95%Jun 2024: 47.95%Sep 2024: 47.95%Dec 2024: 47.95%Mar 2025: 47.37%Jun 2025: 47.37%Sep 2025: 47.37%Dec 2025: 47.37%Mar 2026: 47.37%50.32%47.37%47.37%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters47.37%47.37%47.37%47.37%47.37%47.95%
Public52.63%52.63%52.63%52.63%52.63%52.05%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Promoters47.37%47.37%47.95%50.32%50.32%
Public52.63%52.63%52.05%49.68%49.68%
Promoter change (YoY, %pts)+0.00-0.58-2.37+0.00-

Board & Governance of Shivalik Rasayan Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Shivalik Rasayan Limited has 11 directors - 6 independent and 3 executive. The board is chaired by Rahul Bishnoi.

DirectorPositionOn board sinceListed boards
Sanjay Bansal Non-Executive - Non Independent Director 2018-03-05 2
Rahul Bishnoi Executive Director · Chairperson 2002-02-23 2
Suresh Kumar Singh Executive Director 1997-12-15 2
Ashwani Kumar Sharma Non-Executive - Non Independent Director 2003-07-18 2
Vimal Kumar Shrawat Executive Director · MD 2018-11-17 2
Sumita Dwivedi Non-Executive - Independent Director 2018-11-13 2
Sangeeta Bishnoi Non-Executive - Independent Director 2019-02-11 2
Ravi Kumar Bansal Non-Executive - Independent Director 2019-08-14 2
Ramit Madan Non-Executive - Independent Director 2024-08-13 1
Shaival Saurabh Non-Executive - Independent Director 2024-08-13 2
Sham Goel Non-Executive - Independent Director 2024-08-13 2
Board Committees
CommitteeMembers
Audit Committee Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal
Nomination and remuneration committee Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal
Stakeholders Relationship Committee Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal
Risk Management Committee Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal
Corporate Social Responsibility Committee Suresh Kumar Singh (Chairperson), Sangeeta Bishnoi, Ashwani Kumar Sharma, Sham Goel

Group Structure of Shivalik Rasayan Limited

Shivalik Rasayan Limited has 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Shivalik Rasayan Limited's business expansion strategy and organizational complexity.

1
Associated companies

Charges & Borrowings of Shivalik Rasayan Limited

Open charges
₹110.2 Cr
Satisfied charges
₹21.54 Cr
Breakdown by lending institutions
Citi Bank N.A.₹60.00 Cr
Others₹49.70 Cr
Idbi Bank Limited₹0.29 Cr
Hdfc Bank Limited₹0.21 Cr
Latest charge details
DateLenderAmountStatus
17 Dec 2024 Others ₹20 Lakh Open
22 Jul 2024 Hdfc Bank Limited ₹20.91 Lakh Open
29 Dec 2023 Others ₹49 Cr Open
29 Sep 2023 Idbi Bank Limited ₹17.17 Lakh Open
31 Mar 2023 Citi Bank N.A. ₹15 Cr Open

Total charge records: 18 View all charges

Employees and EPFO Compliance at Shivalik Rasayan Limited

View historical data on people associated with Shivalik Rasayan Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Shivalik Rasayan Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Shivalik Rasayan Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Shivalik Rasayan Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Shivalik Rasayan Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Shivalik Rasayan Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Shivalik Rasayan Limited

MSME Payment Delays by Shivalik Rasayan Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Shivalik Rasayan Limited

Subsidiaries & Group Companies of Shivalik Rasayan Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Shivalik Rasayan Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Shivalik Rasayan Limited

MCA Filings & Documents of Shivalik Rasayan Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Shivalik Rasayan Limited

Activity
27 Sep 2025
Shivalik Rasayan Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Charges
05 May 2025
A charge with Citi Bank N.A. of Rs. 40.00 Cr registered on 21 Apr 2020 with Charge ID 100341163 was modified on 05 May 2025.
Activity
31 Mar 2025
Shivalik Rasayan Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Charges
17 Dec 2024
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 101018035 was registered on 17 Dec 2024.
Directors
13 Aug 2024
Ramit Madan was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 10 months.
Directors
13 Aug 2024
Shaival Saurabh was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 10 months.

Frequently Asked Questions about Shivalik Rasayan Limited

Shivalik Rasayan Limited is an active public limited company in the agriculture sector based in Dehradun, Uttarakhand, India. It was incorporated on 16 March 1979 (47+ years old) and is registered under CIN L24237UR1979PLC005041. Listed on BSE: 539148 and NSE: SHIVALIK.

Shivalik Rasayan Limited reported revenue of ₹320.08 Cr for FY 2025 (up 16.00% YoY).

The primary industry of Shivalik Rasayan Limited is agriculture. The company specifically operates in crop protection. The company is currently active in this sector.

Yes. Shivalik Rasayan Limited is listed on both BSE (code: 539148) and NSE (symbol: SHIVALIK).

Shivalik Rasayan Limited can be reached at the registered office: Village Kolhupani Post Office Chandanwari Via Prem Nagar, Dehradun, Uttarakhand, India – 248007, or through the website shivalikrasayan.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available